These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 561282)

  • 1. Heroin self-administration is under control of vasopressin.
    van Ree JM; de Wied D
    Life Sci; 1977 Aug; 21(3):315-9. PubMed ID: 561282
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular considerations in the interaction of arginine vasopressin with a specific antiserum.
    Burford G; Lutterodt A; Moore G; Lederis K
    Proc West Pharmacol Soc; 1977; 20():521-5. PubMed ID: 896861
    [No Abstract]   [Full Text] [Related]  

  • 3. A highly specific antiserum for arginine vasopressin.
    Moore G; Lutterodt A; Burford G; Lederis K
    Endocrinology; 1977 Nov; 101(5):1421-35. PubMed ID: 913320
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of antisera to [8-arginine]-vasopressin in homozygous Brattleboro rats.
    Lutterodt AT; Burford GD; Lederis K
    J Endocrinol; 1976 Oct; 71(1):161-2. PubMed ID: 978112
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmentation of vasopressin antidiuresis by prolactin with a note on the contamination of International Standard prolactin.
    Waters AK
    J Endocrinol; 1977 Dec; 75(3):435-6. PubMed ID: 412909
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of heroin self-administration by neurohypophyseal principles.
    Van Ree JM; De Wied D
    Eur J Pharmacol; 1977 May; 43(2):199-202. PubMed ID: 872873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early avoidance of a heroin-paired taste-cue and subsequent addiction-like behavior in rats.
    Jenney CB; Petko J; Ebersole B; Njatcha CV; Uzamere TO; Alexander DN; Grigson PS; Levenson R
    Brain Res Bull; 2016 May; 123():61-70. PubMed ID: 26494018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats.
    van Ree JM; Burbach-Bloemarts EM; Wallace M
    Life Sci; 1988; 42(10):1091-9. PubMed ID: 3347140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in sera from patients with multiple sclerosis directed against antigenic determinants in pituitary growth hormone-producing cells and in structures containing vasopressin/oxytocin.
    Møller A; Hansen BL; Hansen GN; Hagen C
    J Neuroimmunol; 1985 May; 8(2-3):177-84. PubMed ID: 3998122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of oxytocin and vasopressin on avoidance behaviour and hippocampal theta rhythm in the rat.
    Bohus B; Urban I; van Wimersma Greidanus TB; de Wied D
    Neuropharmacology; 1978; 17(4-5):239-47. PubMed ID: 652136
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune, neuroendocrine, and somatic alterations in animal models of human heroin abuse.
    Weber RJ; Gomez-Flores R; Smith JE; Martin TJ
    J Neuroimmunol; 2004 Feb; 147(1-2):134-7. PubMed ID: 14741445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence.
    van Ree JM; de Wied D
    Life Sci; 1976 Nov; 19(9):1331-9. PubMed ID: 1033445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of oxytocin and its antagonist microinjected into the hippocampus on the intravenous self-administration of heroin in rats].
    Gasanov GG; Ibragimov RSh; Kovács GL; Szabó G; Telegdy G
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1988; 38(1):129-34. PubMed ID: 3376556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid stimulation by vasopressin, oxytocin and angiotensin II of glycogen degradation in hepatocyte suspensions.
    Hems DA; Rodrigues LM; Whitton PD
    Biochem J; 1978 May; 172(2):311-7. PubMed ID: 666748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nociceptive thresholds by vasopressin in the Brattleboro and normal rat.
    Bodnar RJ; Wallace MM; Kordower JH; Nilaver G; Cort J; Zimmerman EA
    Ann N Y Acad Sci; 1982; 394():735-9. PubMed ID: 6960791
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats.
    Gerrits MA; Petromilli P; Westenberg HG; Di Chiara G; van Ree JM
    Brain Res; 2002 Jan; 924(2):141-50. PubMed ID: 11750899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of hypothalamic corticotropin releasing activity by vasopressin: studies in the Brattleboro rat.
    Buckingham JC
    Ann N Y Acad Sci; 1982; 394():580-6. PubMed ID: 6295234
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunocytochemical specificity for peptides with special reference to arginine-vasopressin and oxytocin.
    van Leeuwen F
    J Histochem Cytochem; 1980 May; 28(5):479-82. PubMed ID: 6991595
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin-dependent and -independent control of the release of adrenocorticotropin.
    Carlson DE; Dornhorst A; Seif SM; Robinson AG; Gann DS
    Endocrinology; 1982 Feb; 110(2):680-2. PubMed ID: 6276148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vasopressin analogues on passive avoidance behavior.
    Krejcí I; Kupková B
    Act Nerv Super (Praha); 1978 Feb; 20(1):11-2. PubMed ID: 636749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.